GUIDETTI, ANNA
GUIDETTI, ANNA
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
A Phase 2 multicenter study of the anti-CD19 antibody drug conjugate coltuximab ravtansine (SAR3419) in patients with relapsed or refractory diffuse large B-cell lymphoma previously treated with rituximab-based immunotherapy
2018 M. Trněný, G. Verhoef, M.J. Dyer, D.B. Yehuda, C. Patti, M. Canales, A. Lopez, F.T. Awan, P.G. Montgomery, A. Janikova, A.M. Barbui, K. Sulek, M.J. Terol, J. Radford, A. Guidetti, M. Di Nicola, L. Siraudin, L. Hatteville, S. Schwab, C. Oprea, A.M. Gianni
A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study
2022 C. Visco, L. Marcheselli, R. Mina, M. Sassone, A. Guidetti, D. Penna, C. Cattaneo, V. Bonuomo, A. Busca, A.J.M. Ferreri, R. Bruna, L. Petrucci, R. Cairoli, M. Salvini, L. Bertù, M. Ladetto, S. Pilerci, A. Pinto, S. Ramadan, F. Marchesi, M. Cavo, L. Arcaini, E. Coviello, A. Romano, P. Musto, M. Massaia, N.S. Fracchiolla, M. Marchetti, A. Scattolin, M.C. Tisi, A. Cuneo, M.G. Della Porta, L. Trentin, M. Turrini, F. Gherlinzoni, A. Tafuri, S. Galimberti, M. Bocchia, V. Cardinali, D. Cilloni, A. Corso, D. Armiento, L. Rigacci, E. Ortu La Barbera, C.B. Gambacorti-Passerini, G. Visani, D. Vallisa, A. Venditti, C. Selleri, A. Conconi, P. Tosi, F. Lanza, A. Candoni, M. Krampera, P. Corradini, F. Passamonti, F. Merli
A prognostic model to predict survival after 6 months of ruxolitinib in patients with myelofibrosis
2022 M. Maffioli, B. Mora, S. Ball, A. Iurlo, E.M. Elli, M.C. Finazzi, N. Polverelli, E. Rumi, M. Caramella, M.C. Carraro, M. D'Adda, A. Molteni, C. Sissa, F. Lunghi, A. Vismara, M. Ubezio, A. Guidetti, S. Caberlon, M. Anghilieri, R.S. Komrokji, D. Cattaneo, M.G. Della Porta, T. Giorgino, L. Bertù, M. Brociner, A.T. Kuykendall, F. Passamonti
Absorbed dose and biologically effective dose in patients with high-risk non-Hodgkin’s lymphoma treated with high-activity myeloablative 90Y-ibritumomab tiuxetan (Zevalin®)
2009 C. Chiesa, F. Botta, A. Coliva, M. Maccauro, L. Devizzi, A. Guidetti, C. Carlo-Stella, E. Seregni, A.M. Gianni, E. Bombardieri
Age- and irradiation-associated loss of bone marrow hematopoietic function in mice is reversed by recombinant human growth hormone (rhGH)
2004 C. Carlo-Stella, M. Di Nicola, R. Milani, P. Longoni, M. Milanesi, C. Bifulco, C. Stucchi, A. Guidetti, L. Cleris, F. Formelli, G. Garotta, A.M. Gianni
Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma
2021 R.W. Merryman, L. Castagna, L. Giordano, V.T. Ho, P. Corradini, A. Guidetti, B. Casadei, D.A. Bond, S. Jaglowski, M.A. Spinner, S. Arai, R. Lowsky, G.L. Shah, M.-. Perales, J.M.S. De Colella, D. Blaise, A.F. Herrera, G. Shouse, C. Spilleboudt, S.M. Ansell, Y. Nieto, T. Badar, M. Hamadani, T.A. Feldman, L. Dahncke, A.K. Singh, J.P. McGuirk, T. Nishihori, J. Chavez, A.V. Serritella, J. Kline, M. Mohty, R. Dulery, A. Stamatoulas, R. Houot, G. Manson, M.-. Moles-Moreau, C. Orvain, K. Bouabdallah, D. Modi, R. Ramchandren, L. Lekakis, A. Beitinjaneh, M.J. Frigault, Y.-. Chen, R.C. Lynch, S.D. Smith, U. Rao, M. Byrne, J.T. Romancik, J.B. Cohen, S. Nathan, T. Phillips, R.M. Joyce, M. Rahimian, A. Bashey, H.J. Ballard, J. Svoboda, V. Torri, M. Sollini, C. De Philippis, M. Magagnoli, A. Santoro, P. Armand, P.L. Zinzani, C. Carlo-Stella
Allogeneic transplantation for relapsed and refractory Hodgkin lymphoma : long-term outcomes and graft-versus-host disease-free/relapse-free survival
2018 F. Spina, T. Radice, C. De Philippis, M. Soldarini, M.C. Di Chio, A. Dodero, A. Guidetti, S. Viviani, P. Corradini
Are We Ready to Treat Diffuse Large B-cell and High-Grade Lymphoma According to Major Genetic Subtypes?
2019 A. Chiappella, J. Crombie, A. Guidetti, U. Vitolo, P. Armand, P. Corradini
Boosting T cell-mediated immunity to tyrosinase by vaccinia virus-transduced, CD34+-derived dendritic cell vaccination: a phase I trial in metastatic melanoma
2004 M. Di Nicola, C. Carlo-Stella, R. Mortarini, P. Baldassari, A. Guidetti, F. Gallino, M. Del Vecchio, F. Ravagnani, M. Magni, P. Chaplin, N. Cascinelli, G. Parmiani, A. Gianni, A. Anichini
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies : results from EPICOVIDEHA survey
2022 L. Pagano, J. Salmanton-García, F. Marchesi, O. Blennow, M. Gomes da Silva, A. Glenthøj, J.A. van Doesum, Y.M. Bilgin, A. Lopez-Garcia, F. Itri, R. Nunes Rodrigues, B. Weinbergerová, F. Farina, G. Dragonetti, C. Berg Venemyr, J. Van Praet, O. Jaksic, T. Valkovic, I. Falces-Romero, S. Martin-Perez, M. Jiménez, J. Davila-Valls, M. Schonlein, E. Ammatuna, S. Meers, M. Delia, Z. Stojanoski, A. Nordlander, T. Lahmer, L.I. Pinczés, C. Buquicchio, K. Piukovics, I. Ormazabal-Velez, N.S. Fracchiolla, M. Samarkos, G. Mendez, J. Hernández-Rivas, I. Espigado, M. Cernan, V. Petzer, S. Lamure, R. Di Blasi, J. Marques de Almeida, M. Dargenio, M.M. Biernat, M. Sciumè, C. de Ramón, N.A. De Jonge, J. Batinic, A. Aujayeb, M. Marchetti, G. Fouquet, N. Fernández Escalada, G.P.M. Zambrotta, M.V. Sacchi, A. Guidetti, F. Demirken, L. Prezioso, Z. Racil, M. Nucci, M. Mladenovic, R. Lievin, M. Hanakova, S.K. Grafe, U. Sili, M. Machado, C. Cattaneo, T. Adzic-Vukicevic, L. Verga, J. Labrador, L. Rahimli, M. Bonanni, F. Passamonti, A. Pagliuca, P. Corradini, M. Hoenigl, P. Koehler, A. Busca, O.A. Cornely
CD52 antigen expressed by malignant plasma cells can be targeted by alemtuzumab in vivo in NOD/SCID mice
2006 C. Carlo-Stella, A. Guidetti, M. Di Nicola, P. Longoni, L. Cleris, C. Lavazza, M. Milanesi, R. Milani, M. Carrabba, L. Farina, F. Formelli, A.M. Gianni, P. Corradini
Chemotherapy after PD-1 inhibitors in relapsed/refractory Hodgkin lymphoma: Outcomes and clonal evolution dynamics
2022 E. Calabretta, A. Guidetti, F. Ricci, M. Di Trani, C. Monfrini, M. Magagnoli, S. Bramanti, D. Maspero, L. Morello, M. Merli, A. Di Rocco, A. Graudenzi, E. Derenzini, M. Antoniotti, D. Rossi, P. Corradini, A. Santoro, C. Carlo-Stella
Clinical protocol. Immunization of patients with malignant melanoma with autologous CD34+ cell-derived dendritic cells transduced ex vivo with a recombinant replication-deficient vaccinia vector encoding the human tyrosinase gene: a phase I trial
2003 M. Di Nicola, C. Carlo-Stella, A. Anichini, R. Mortarini, A. Guidetti, G. Tragni, F. Gallino, M. Del Vecchio, F. Ravagnani, D. Morelli, P. Chaplin, N. Arndtz, G. Sutter, I. Drexler, G. Parmiani, N. Cascinelli, A.M. Gianni
Combination of Deauville score and quantitative positron emission tomography parameters as a predictive tool of anti-CD19 chimeric antigen receptor T-cell efficacy
2023 A. Guidetti, A. Dodero, A. Lorenzoni, S. Pizzamiglio, G. Argiroffi, A. Chiappella, F. Bagnoli, V. Marasco, C. Carniti, C. Monfrini, E. Seregni, M. Pennisi, P. Verderio, A. Alessi, P. Corradini
Coronavirus Disease 2019 in Recipient of Allogeneic Hematopoietic Stem Cell Transplantation : Life-threating Features Within the Early Post-engraftment Phase
2020 C. Oltolini, A. Guidetti, M. Ripa, B. Castiglioni, C. Tassan Din, S. Mastaglio, D. Canetti, G. Monti, A. Andolina, C. Molinari, A. Poloniato, A. Mastrangelo, M. Ferrante, M. Lanzillotta, P. Scarpellini, A. Castagna, P. Corradini, F. Ciceri
COVID-19 and CAR-T cells: current challenges and future directions-a report from the EPICOVIDEHA survey by EHA-IDWP
2021 A. Busca, J. Salmanton-García, P. Corradini, F. Marchesi, A. Cabirta, R. Di Blasi, R. Dulery, S. Lamure, F. Farina, B. Weinbergerová, J. Batinić, A. Nordlander, A. Lopez-Garcia, L. Drgona, I. Espigado, I. Falces-Romero, R. Garcia-Sanz, C. Garcia-Vidal, A. Guidetti, N. Khanna, A. Kulesekararaj, J. Maertens, M. Hoenigl, N. Klimko, P. Koehler, A. Pagliuca, F. Passamonti, O. Cornely, L. Pagano
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)
2021 L. Pagano, J. Salmanton-Garcia, F. Marchesi, A. Busca, P. Corradini, M. Hoenigl, N. Klimko, P. Koehler, A. Pagliuca, F. Passamonti, L. Verga, B. Visek, O. Ilhan, G. Nadali, B. Weinbergerova, R. Cordoba-Mascunano, M. Marchetti, G.P. Collins, F. Farina, C. Cattaneo, A. Cabirta, M. Gomes-Silva, F. Itri, J. van Doesum, M.-. Ledoux, M. Cernan, O. Jaksic, R.F. Duarte, G. Magliano, A.S. Omrani, N.S. Fracchiolla, A. Kulasekararaj, T. Valkovic, C.B. Poulsen, M. Machado, A. Glenthoj, I. Stoma, Z. Racil, K. Piukovics, M. Navratil, Z. Emarah, U. Sili, J. Maertens, O. Blennow, R. Bergantim, C. Garcia-Vidal, L. Prezioso, A. Guidetti, M.I. del Principe, M. Popova, N. de Jonge, I. Ormazabal-Velez, N. Fernandez, I. Falces-Romero, A. Cuccaro, S. Meers, C. Buquicchio, D. Antic, M. Al-Khabori, R. Garcia-Sanz, M.M. Biernat, M.C. Tisi, E. Sal, L. Rahimli, N. Colovic, M. Schonlein, M. Calbacho, C. Tascini, C. Miranda-Castillo, N. Khanna, G.-. Mendez, V. Petzer, J. Novak, C. Besson, R. Dulery, S. Lamure, M. Nucci, G. Zambrotta, P. Zak, G.C. Seval, V. Bonuomo, J. Mayer, A. Lopez-Garcia, M.V. Sacchi, S. Booth, F. Ciceri, M. Oberti, M. Salvini, M. Izuzquiza, R. Nunes-Rodrigues, E. Ammatuna, A. Obr, R. Herbrecht, L. Nunez-Martin-Buitrago, V. Mancini, H. Shwaylia, M. Sciume, J. Essame, M. Nygaard, J. Batinic, Y. Gonzaga, I. Regalado-Artamendi, L.K. Karlsson, M. Shapetska, M. Hanakova, S. El-Ashwah, Z. Borbenyi, G.M. Colak, A. Nordlander, G. Dragonetti, A.M.E. Maraglino, A. Rinaldi, C. De Ramon-Sanchez, O.A. Cornely, O. Finizio, R. Fazzi, G. Sapienza, A. Chauchet, J. Van Praet, J. Prattes, M. Dargenio, C. Rossi, A. Shirinova, S. Malak, A. Tafuri, H.-. Ommen, S. Bologna, R.A. Khedr, S. Choquet, B. Joly, M.M. Ceesay, L. Philippe, C.S. Kho, M. Desole, P. Tsirigotis, V. Otasevic, D.M.M. Borducchi, A. Antoniadou, J. Gaziev, M.A. Almaslamani, N. Garcia-Pouton, G. Paterno, A. Torres-Lopez, G. Tarantini, S. Mellinghoff, S. Grafe, N. Borschel, J. Passweg, M. Merelli, A. Barac, D. Wolf, M.U. Shaikh, C. Thieblemont, S. Bernard, V.A.M. Funke, E. Daguindau, S. Khostelidi, F.M. Nucci, J.-. Martin-Gonzalez, M. Landau, C. Soussain, C. Laureana, K. Lacombe, M. Kohn, G. Aliyeva, M. Piedimonte, G. Fouquet, M. Rego, B. Hoell-Neugebauer, G. Cartron, F. Pinto, A.M. Alburquerque, J. Passos, A.F. Yilmaz, A.-. Redondo-Izal, F. Altuntas, C. Heath, M. Kolditz, E. Schalk, F. Guolo, M. Karthaus, R. Della Pepa, D. Vinh, N. Noel, B. Deau Fischer, B. Drenou, M.E. Mitra, J. Meletiadis, Y.M. Bilgin, P. Jindra, I. Espigado, L. Drgona, A. Serris, R. Di Blasi, N. Ali
Cytokine secretion associated with the clearance of apoptotic bodies in renal cell carcinoma patients
2001 A. Bondanza, P. Rovere, A. Borri, E.R. Caremoli, A. Guidetti, G. Citterio, G. Consogno, V.S. Zimmermann, C. Rugarli, A.A. Manfredi
Detection of minimal residual disease in hematopoietic progenitor cell harvests : lack of predictive value of peripheral blood and bone marrow analysis in mantle cell and indolent lymphoma
2012 M. Magni, M.D. Nicola, C. Carlo-Stella, P. Matteucci, L. Devizzi, A. Guidetti, F. Ravagnani, A.M. Gianni
Dose-Adjusted Epoch and Rituximab for the treatment of double expressor and double hit diffuse large B-cell lymphoma: impact of TP53 mutations on clinical outcome
2021 A. Dodero, A. Guidetti, F. Marino, A. Tucci, F. Barretta, A. Re, M. Balzarotti, C. Carniti, C. Monfrini, A. Chiappella, A. Cabras, F. Facchetti, M. Pennisi, D. Rahal, V. Monti, L. Devizzi, R. Miceli, F. Cocito, L. Farina, F. Ricci, G. Rossi, C. Carlo-Stella, P. Corradini